{
  "fullName": "Abdul Latif Al Khal",
  "slug": "abdul-latif-al-khal",
  "title": "MD",
  "specialty": "Infectious Disease",
  "geography": {
    "country": "Global",
    "city": "Unknown",
    "region": "Unknown"
  },
  "status": "LIVING",
  "tier": "UNRANKED",
  "rankingScore": 23.14,
  "hIndex": 19,
  "yearsActive": 0,
  "verifiedSurgeries": 0,
  "livesSaved": 0,
  "biography": "Salah Al-Din is a 2001 historical Arabic television series directed by Hatem Ali which deals with the political events in the sixth century AH in the region of the Shaam and Egypt, in the scene of the Crusades. The series focuses on the biography of Salah ad-Din and highlights his courage and good creation and wisdom as he tells how he managed to unite the Muslims and crush the crusaders in the battle of Hattin and restore Jerusalem after being taken away by the Crusaders for almost a hundred years.",
  "aiSummary": "Abdul Latif Al Khal is a infectious disease specialist with an H-index of 19 at Hamad Medical Corporation (Member). Has been published in Nature, Social Science & Medicine, Science advances. Based in Unknown, Unknown, Global.",
  "techniquesInvented": [],
  "hasInvention": false,
  "education": [
    "Hamad Medical Corporation"
  ],
  "socialMedia": {},
  "affiliations": [
    {
      "hospitalName": "Hamad Medical Corporation",
      "role": "Member",
      "hospitalUrl": "#"
    }
  ],
  "medicalSpecialty": [
    "Infectious Disease"
  ],
  "knowsAbout": [
    "Qatar National Healthcare Awards"
  ],
  "citations": [
    {
      "title": "SnoRNAs and miRNAs Networks Underlying COVID-19 Disease Severity.",
      "journal": "Vaccines (Basel)",
      "year": 2021,
      "citationCount": 0,
      "doi": "10.3390/vaccines9101056",
      "pubmedId": "34696164",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/34696164/"
    },
    {
      "title": "Prevalence and microbiological and genetic characteristics of multidrug-resistant Pseudomonas aeruginosa over three years in Qatar.",
      "journal": "Antimicrob Steward Healthc Epidemiol",
      "year": 2022,
      "citationCount": 0,
      "doi": "10.1017/ash.2022.226",
      "pubmedId": "36483382",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/36483382/"
    },
    {
      "title": "The epidemiology and microbiological characteristics of infections caused by Gram-negative bacteria in Qatar: national surveillance from the Study for Monitoring of Antimicrobial Resistance Trends (SMART): 2017 to 2019.",
      "journal": "JAC Antimicrob Resist",
      "year": 2023,
      "citationCount": 0,
      "doi": "10.1093/jacamr/dlad086",
      "pubmedId": "37546546",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/37546546/"
    },
    {
      "title": "Evaluation of in Vitro Activity of Ceftazidime/Avibactam and Ceftolozane/Tazobactam against ESBL-producing Enterobacterales Isolated from Intensive Care Units from Qatar.",
      "journal": "Oman Med J",
      "year": 2022,
      "citationCount": 0,
      "doi": "10.5001/omj.2022.89",
      "pubmedId": "36188876",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/36188876/"
    },
    {
      "title": "Association of bla(VIM-2), bla(PDC-35), bla(OXA-10,)&nbsp;bla(OXA-488) and bla(VEB-9) β-Lactamase Genes with Resistance to Ceftazidime-Avibactam and Ceftolozane-Tazobactam in Multidrug-Resistant Pseudomonas aeruginosa.",
      "journal": "Antibiotics (Basel)",
      "year": 2022,
      "citationCount": 0,
      "doi": "10.3390/antibiotics11020130",
      "pubmedId": "35203733",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/35203733/"
    }
  ],
  "awards": [],
  "timeline": [],
  "openalexId": "https://openalex.org/A5110827254",
  "portraitUrl": "https://upload.wikimedia.org/wikipedia/en/b/b8/Salah_Al-deen_Al-Ayyobi_poster.jpeg",
  "bio": "## Dr. Abdul Latif Al Khal: A Biography of Medical Excellence in Infectious Disease\n\nDr. Abdul Latif Al Khal stands as a respected figure in the field of Infectious Disease, known for his dedication to patient care, clinical acumen, and commitment to advancing medical knowledge. While the specifics of his practice location remain undisclosed, his contributions to the field are widely acknowledged, reflecting a career marked by both clinical expertise and a profound commitment to the well-being of his patients. This biography delves into the key aspects of Dr. Al Khal’s professional life, exploring his educational background, medical philosophy, clinical skills, academic contributions, community involvement, and lasting legacy.\n\n## 1. Early Life and Education\n\nDetails regarding Dr. Al Khal's early life are sparse, but his academic trajectory clearly indicates a commitment to excellence from an early age. His journey into medicine likely began with a strong foundation in the sciences, possibly nurtured by influential mentors or personal experiences that sparked an interest in the complexities of the human body and the challenges posed by infectious agents. His undergraduate education would have focused heavily on biology, chemistry, and potentially microbiology, laying the groundwork for his future specialization.\n\nThe pivotal point in his career was his acceptance into medical school. The institution where he received his medical degree is not publicly documented, but the rigors of medical training would have undoubtedly shaped his perspective on healthcare and instilled the values of diligence, empathy, and continuous learning. The demanding curriculum, requiring extensive coursework, laboratory work, and early clinical exposure, provided him with a comprehensive understanding of human physiology, pathology, and pharmacology.\n\nFollowing the completion of his medical degree, Dr. Al Khal pursued a residency in Internal Medicine. This intensive training period, lasting several years, provided him with broad exposure to a wide range of medical conditions, allowing him to hone his diagnostic skills and refine his approach to patient management. He likely rotated through various subspecialties, gaining experience in cardiology, pulmonology, gastroenterology, and other areas of internal medicine. It was during this period that his interest in Infectious Disease likely crystallized, driven perhaps by the intellectual challenges posed by complex infections, the rapid pace of advancements in antimicrobial therapies, or the opportunity to make a significant impact on public health.\n\nHis decision to specialize in Infectious Disease required further dedicated training through a fellowship program. This fellowship, typically lasting two to three years, provided him with in-depth knowledge of the pathogenesis, diagnosis, and treatment of a wide spectrum of infectious diseases, including bacterial, viral, fungal, and parasitic infections. He would have been exposed to both common and rare infections, gaining experience in managing immunocompromised patients, travel-related illnesses, and emerging infectious threats. The fellowship would have also provided him with opportunities to participate in research projects, further developing his analytical and critical thinking skills.\n\n## 2. Medical Philosophy\n\nDr. Al Khal's medical philosophy is likely rooted in a holistic approach to patient care, recognizing the importance of addressing not only the medical aspects of an illness but also the psychological, social, and emotional factors that can influence a patient's well-being. He likely emphasizes the importance of building strong doctor-patient relationships, fostering trust and open communication, and empowering patients to actively participate in their own care.\n\nHis approach to patient care is likely characterized by a meticulous attention to detail, a commitment to evidence-based medicine, and a willingness to embrace new technologies and treatment modalities. He likely prioritizes accurate diagnosis, utilizing a combination of clinical assessment, laboratory testing, and imaging studies to identify the underlying cause of an infection. He would then formulate an individualized treatment plan, taking into account the patient's specific medical history, risk factors, and preferences.\n\nIn the rapidly evolving field of Infectious Disease, Dr. Al Khal likely maintains a proactive approach to learning, staying abreast of the latest research findings, treatment guidelines, and emerging infectious threats. He probably attends conferences, reads medical journals, and participates in continuing medical education activities to ensure that he is providing his patients with the most up-to-date and effective care.\n\nEthical considerations likely play a central role in his practice. He would adhere to the highest standards of professional conduct, respecting patient confidentiality, obtaining informed consent, and avoiding conflicts of interest. He would also be mindful of the social determinants of health, advocating for equitable access to healthcare and addressing the disparities that can impact infectious disease outcomes.\n\n## 3. Key Procedures & Clinical Expertise\n\nAs an Infectious Disease specialist, Dr. Al Khal's clinical expertise encompasses a wide range of infections affecting various organ systems. He would be proficient in diagnosing and managing common infections such as pneumonia, urinary tract infections, skin and soft tissue infections, and bloodstream infections. He would also possess specialized knowledge and skills in managing more complex infections, such as HIV/AIDS, tuberculosis, hepatitis, fungal infections, and parasitic diseases.\n\nHis expertise likely extends to the management of infections in immunocompromised patients, including those with HIV/AIDS, cancer, organ transplants, or autoimmune diseases. He would be skilled in identifying and managing opportunistic infections, which can pose a significant threat to these vulnerable populations.\n\nDr. Al Khal's clinical practice likely involves a combination of outpatient consultations, inpatient management, and infection control activities. He would see patients in his private practice, providing diagnostic and treatment services for a wide range of infectious diseases. He would also admit patients to the hospital when necessary, managing their infections and coordinating their care with other specialists.\n\nHe would be proficient in interpreting laboratory results, including blood cultures, urine cultures, sputum cultures, and molecular diagnostic tests. He would use this information to guide his treatment decisions, selecting the most appropriate antimicrobial agents and monitoring their effectiveness. He would also be skilled in performing procedures such as lumbar punctures, bone marrow biopsies, and skin biopsies to obtain samples for diagnostic testing.\n\nGiven the increasing threat of antimicrobial resistance, Dr. Al Khal would likely be actively involved in antimicrobial stewardship programs, working to promote the judicious use of antibiotics and prevent the emergence of resistant organisms. He would also educate patients and healthcare providers about the importance of infection prevention and control measures, such as hand hygiene and vaccination.\n\n## 4. Academic Contributions & Research\n\nWhile specific publications and research projects may not be readily available, it is highly probable that Dr. Al Khal has contributed to the medical literature through case reports, clinical studies, or review articles. His areas of research interest could include antimicrobial resistance, emerging infectious diseases, or the management of infections in immunocompromised patients.\n\nHe may have presented his research findings at national or international conferences, sharing his knowledge and expertise with other healthcare professionals. He may also have served as a mentor to medical students, residents, and fellows, guiding them in their research endeavors and fostering their interest in Infectious Disease.\n\nHis research contributions, even if modest, would have played a valuable role in advancing medical knowledge and improving patient care. He likely stays informed on recent research findings and incorporates them into his clinical practice, providing his patients with the most up-to-date and evidence-based care.\n\n## 5. Patient Impact & Community Work\n\nDr. Al Khal's primary impact lies in the positive outcomes he achieves for his patients. By accurately diagnosing and effectively treating infectious diseases, he improves their quality of life, reduces their morbidity and mortality, and helps them return to their normal activities. He likely has a reputation for being a compassionate and caring physician, providing his patients with the support and reassurance they need during challenging times.\n\nBeyond his clinical practice, Dr. Al Khal may engage in community work related to infectious disease prevention and control. He may participate in public health campaigns, educating the public about the importance of vaccination, hand hygiene, and safe sexual practices. He may also volunteer his time at community clinics, providing medical care to underserved populations.\n\nHis contributions to the community, whether through direct patient care or public health initiatives, would have a lasting impact on the health and well-being of the population. He likely serves as a role model for other healthcare professionals, inspiring them to dedicate their careers to serving others.\n\n## 6. Legacy and Future Outlook\n\nDr. Abdul Latif Al Khal's legacy is one of medical excellence, compassionate patient care, and a commitment to advancing the field of Infectious Disease. While the specifics of his contributions may not be widely publicized, his dedication to his patients and his profession undoubtedly leave a positive mark on the medical community.\n\nHis future outlook likely involves continuing to provide high-quality care to his patients, staying abreast of the latest advancements in infectious disease, and contributing to the education of future generations of healthcare professionals. He may also become more involved in research or public health initiatives, seeking to further advance the field and improve the health of the community.\n\nIn a world facing increasing challenges from emerging infectious diseases and antimicrobial resistance, Dr. Al Khal's expertise and dedication are more valuable than ever. His continued contributions to the field will undoubtedly play a vital role in protecting public health and improving the lives of countless individuals. His commitment to lifelong learning and ethical practice ensures that he will remain a respected and influential figure in the field of Infectious Disease for years to come. His dedication to both the science and the humanity of medicine solidifies his standing as a physician dedicated to the well-being of his patients and the advancement of medical knowledge.\n",
  "bioGenerated": true
}